The Vertigo Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Vertigo Treatment Global Market has experienced substantial growth in the past years. Its market size is projected to increase from $1.58 billion in 2024 to $1.68 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.1%.
The vertigo treatment market is predicted to expand significantly in the coming years, reaching a value of $2.10 billion by 2029. This represents a compound annual growth rate (CAGR) of 5.7%.
Download Your Free Sample of the 2025 Vertigo Treatment Market Report and Uncover Key Trends Now!The key drivers in the vertigo treatment market are:
• Increasing number of clinical trials
• Rising emergence and availability of vertigo-specific drugs
• Government initiatives supporting research and treatment
• Technological advancements in device-based therapies and telehealth services
The vertigo treatment market covered in this report is segmented –
1) By Type: Peripheral Vertigo, Central Vertigo
2) By Treatment: Medication, Surgery, Therapy
3) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
4) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Peripheral Vertigo: Benign Paroxysmal Positional Vertigo (BPPV), Meniere’s Disease, Vestibular Neuritis, Labyrinthitis
2) By Central Vertigo: Vestibular Migraine, Stroke-Related Vertigo, Multiple Sclerosis-Associated Vertigo, Brain Tumor-Related Vertigo
The key trends in the vertigo treatment market are:
• Novel vertigo-related therapeutics are an emerging trend in the market.
• Telehealth services are becoming increasingly relevant in the treatment of vertigo.
• Device-based therapies are trending in this market.
• Technological advancements and strategic collaborations are crucial future influencing factors.
Major players in the vertigo treatment market are:
• Pfizer Inc.
• Abbott Laboratories
• Medtronic Plc
• Boston Scientific Corp.
• Eisai Co. Ltd.
• Lupin Ltd.
• Vertigenius
• Kracie Holdings Ltd.
• Biologische Heilmittel Heel GmbH
• Interacoustics A/S.
• AdvaCare Pharma
• AuroPharma Inc.
• Biofield Pharma Pvt Ltd.
• Sound Pharmaceuticals Inc.
• Otolith Labs Inc.
• Ear Technology Corporation
• NeuroEquilibrium Diagnostic Systems Pvt Ltd.
• Vestibular First
• Natus Medical Incorporated
• Ronish Bioceuticals
North America was the largest region in the vertigo treatment market in 2024